Rwanda

in page functions
[French]
Total population (2016) 11,882,752
Birth cohort (2016) 363,074
Surviving Infants (surviving to 1 year per year, 2016) 346,991
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 31/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 42/1000
World Bank Index, IDA (2012) 3.84
Co-financing status (2016) Initial self-financing
No. of districts/territories (2014) 30

Gavi support for Rwanda

Type of support

Approvals

2001-2020 (US$)
(30 Apr 2016)

Commitments

2001-2020 (US$)
(30 Apr 2016)

Disbursements

2000-2016 (US$)
(30 Apr 2016)

% Disbursed

(30 Apr 2016)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Health system strengthening (HSS 1) $5,605,000 $5,605,000 $5,605,000 100%
Health system strengthening (HSS 2) $7,384,840 $11,323,970 $4,439,957 60%
HPV (NVS) $4,723,046 $6,132,046 $4,716,707 100%
Immunisation services support (ISS) $2,958,700 $2,958,700 $2,958,700 100%
Injection safety support (INS) $369,500 $369,500 $369,500 100%
IPV (NVS) $898,872 $1,490,372 $590,829 66%
Measles (NVS) $307,000 $473,000 $48,094 16%
Measles-Rubella (NVS) $3,549,500 $3,549,500 $3,622,489 102%
MR - Operational costs (OPC) $3,279,500 $3,279,500 $3,279,500 100%
Penta (NVS) $45,674,835 $47,177,835 $45,915,488 101%
Pneumo (NVS) $29,682,948 $33,473,448 $30,338,969 102%
Rotavirus (NVS) $25,673,686 $28,880,186 $23,009,280 90%
Vaccine Introduction Grant (VIG) $1,686,650 $1,686,650 $1,403,650 83%
Total $131,794,076 $146,399,706 $126,298,163

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Rwanda DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2014)

Grade of confidence


N/A
DTP3 - Official country estimates (2014) 98%
M:F sex ratio at birth (2016) 1.02
Household survey: DTP3 coverage for male (2009) 97.10%
Household survey: DTP3 coverage for female (2009) 96.50%
Household survey: Last DTP3 survey (2009) 97%
% districts achieving > 80% DTP3 coverage (2014) 100%
% districts achieving < 50% DTP3 coverage (2014) 0%
MCV WHO/UNICEF estimates (2014) 98%

Breakdown of support

Non-vaccine support Vaccine support
14% 86%
$18,056,307 $108,241,853

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Rwanda

19 April 2016

Alan Brooks

Setting new standards: East Africa's Centre of Excellence for health supply chains

Gavi’s Alan Brooks explains how the launch of a new Centre of Excellence for vaccines, immunisation and health supply chain management in Rwanda will drive the modernisation of immunisation supply chains across East Africa.

22 February 2016

Gavi item

Meningitis A nearly eliminated in Africa through vaccination

Joint press release first published by WHO and PATH, joint founders of the Meningitis Vaccine Project.

07 February 2016

Africa United

Seth Berkley helps kick-off Africa United universal immunisation campaign

Gavi CEO attends final of 2016 African Nations football championship to support launch of ‘Every Shot Counts’.

close icon

modal window here